Yu Mi Kang MD PhD (She/Her)
Diabetes, Lipid Metabolism, Obesity
Division of Endocrinology, Diabetes and Hypertension, Harvard Medical School/Brigham and Women's Hospital
Join to View Full Profile
221 Longwood AveBoston, MA 02115
Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Clinical areas of experience include management of diabetes, obesity, and metabolic disorders. Research interests are (1) investigating the prognosis of various cardiometabolic conditions including type 2 diabetes and obesity through big-data analyses and (2) cardiovascular effects of novel antidiabetic therapies such as DPP4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors.
Education & Training
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2019 - 2022- Bridgeport Hospital/Yale UniversityInternship, Internal Medicine, 2019 - 2020
University of Ulsan College of MedicinePh.D., Internal Medicine / Cardiovascular diabetology, 2013 - 2015- OtherClass of 2010, MD-MSc
- University of TorontoB.Sc., Integrative Biology, 2002 - 2005
Certifications & Licensure
MA State Medical License 2021 - 2025
CT State Medical License 2019 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Korean Endocrine Society Board Certification of Endocrinology- The Korean Association of Internal MedicineBoard of Internal Medicine
Awards, Honors, & Recognition
- Outstanding Abstract Award Endocrine Society, 2021
- Hospitalist Choice Award Internal Medicine, Yale New Haven Health: Bridgeport Hospital, 2020
- Platinum Certificate of Appreciation Yale New Haven Health, 2019
- Join now to see all
Publications & Presentations
PubMed
- Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo-controlled clinical trials.Yu Mi Kang, Viktoria Punov, Soo Lim, Michael A Nauck
Diabetes, Obesity & Metabolism. 2025-04-11 - Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trial.Brian A Bergmark, Nicholas A Marston, Thomas A Prohaska, Veronica J Alexander, Andre Zimerman
American Heart Journal. 2025-03-11 - Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.Nicholas A Marston, Brian A Bergmark, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, Yu Mi Kang
American Heart Journal. 2025-03-09
Grant Support
- Korean Diabetes Prevention Study - Pilot projectKorean Center for Disease Control2015–2016
Committees
- Vice Secretary, Scientific Committee, Korean Society of Lipid and Atherosclerosis 2019 - Present
- Vice Secretary, Scientific Committee, Korean Society for the Study of Obesity 2016 - 2018
Research History
- Characterization of diabetic population in KoreaUtilizing a national cohort in Korea, ran clinical and translational research topics on characterizing a diabetic population and predicting cardiometabolic and mortality outcomes.2016 - 2019
- Safety and effect of incretin-based antidiabetic medicationsInvolved different forms of research such as direct clinical trial (DPP4 inhibitors), meta-analyses, and reviews. Emphasis was on the ethnic difference.2015 - 2019
- Characterization of metabolically healthy obese populationClinical and translational research topics on characterizing a metabolically healthy obese (MHO) population and predicting cardiometabolic and mortality outcomes.2015 - 2019
Professional Memberships
- Korean Diabetes AssociationMember
- Korean Endocrine SocietyMember
- Korean Society of Lipid and AtherosclerosisMember
- Korean Society for the Study of ObesityMember
- European Association for the Study of DiabetesMember
- Member
- Endocrine SocietyMember
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
